Hereditary spherocytosis: genes and variants
Explore variant evidence for Hereditary spherocytosis across 3 analyzed proteins (SLC4A1, SPTB, SPTA1). Linked ClinVar records include 22 pathogenic or likely pathogenic variants, 145 variants of uncertain significance and 97 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Hereditary spherocytosis
SLC4A1: Band 3 anion transport protein
In red blood cells it exchanges chloride and bicarbonate to support carbon-dioxide transport, while in renal intercalated cells it is required for acid-base regulation. Pathogenic variants can cause hereditary spherocytosis or distal renal tubular acidosis depending on the affected function.
13 ClinVar pathogenic / likely pathogenic and 82 uncertain variants in SLC4A1 have source records linked to Hereditary spherocytosis. Association strength is not clinical gene validity.
SPTB: Spectrin beta chain, erythrocytic
It contributes beta-spectrin to the red-blood-cell membrane skeleton, linking the lipid bilayer to actin and ankyrin complexes. Pathogenic variants can cause hereditary spherocytosis, elliptocytosis, or related congenital hemolytic anemia.
7 ClinVar pathogenic / likely pathogenic and 38 uncertain variants in SPTB have source records linked to Hereditary spherocytosis. Association strength is not clinical gene validity.
SPTA1: Spectrin alpha chain, erythrocytic 1
It forms the alpha-spectrin lattice underlying the red-blood-cell membrane and provides elasticity needed to survive repeated passage through the circulation. Pathogenic variants cause hereditary elliptocytosis, hereditary spherocytosis, or severe hereditary pyropoikilocytosis.
2 ClinVar pathogenic / likely pathogenic and 122 uncertain variants in SPTA1 have source records linked to Hereditary spherocytosis. Association strength is not clinical gene validity.
Where Hereditary spherocytosis variants cluster
- SPTB Spectrin 17 (positions 2013–2075): 3 of 7 ClinVar pathogenic / likely pathogenic variants, 14.5× more than its size predicts (a length-based count, not a validated hotspot).
- SLC4A1 (Microbial infection) 5ABC region (positions 720–761): 4 of 13 ClinVar pathogenic / likely pathogenic variants, 6.7× more than its size predicts (a length-based count, not a validated hotspot).
- SLC4A1 Transmembrane (positions 486–506): 3 of 13 ClinVar pathogenic / likely pathogenic variants, 10.0× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Hereditary spherocytosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SLC4A1 R490H | 490 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC4A1 R490C | 490 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC4A1 R760Q | 760 | (Microbial infection) 5ABC region | Pathogenic / likely pathogenic (★★) |
| SLC4A1 R808H | 808 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC4A1 R589C | 589 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC4A1 R589H | 589 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC4A1 G701D | 701 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC4A1 R760W | 760 | (Microbial infection) 5ABC region | Pathogenic / likely pathogenic (★★) |
| SLC4A1 V488M | 488 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC4A1 G609R | 609 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SPTB R216Q | 216 | Calponin-homology (CH) 2 | Pathogenic / likely pathogenic (★★) |
| SPTB S2019P | 2019 | Spectrin 17 | Pathogenic / likely pathogenic (★★) |
| SPTA1 R28H | 28 | Pathogenic / likely pathogenic (★★) | |
| SLC4A1 A737V | 737 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC4A1 L441R | 441 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC4A1 G720V | 720 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SPTA1 L567P | 567 | Spectrin 5 | Pathogenic / likely pathogenic (★) |
| SPTB A49V | 49 | Actin-binding | Pathogenic / likely pathogenic (★) |
| SPTB R156P | 156 | Calponin-homology (CH) 1 | Pathogenic / likely pathogenic (★) |
| SPTB T2040I | 2040 | Spectrin 17 | Pathogenic / likely pathogenic (★) |
| SPTB W202R | 202 | Calponin-homology (CH) 2 | Pathogenic / likely pathogenic |
| SPTB L2032P | 2032 | Spectrin 17 | Pathogenic / likely pathogenic |
Which prediction tools work for Hereditary spherocytosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- REVEL: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 95 out of 100
- MetaLR: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 89 out of 100
- SIFT: 88 out of 100
- CADD: 88 out of 100
- SpliceAI: 60 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 39 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Autosomal dominant distal renal tubular acidosis also has ClinVar records linked to SLC4A1 variants; they fall mostly in different places as the Hereditary spherocytosis variants (11 pathogenic / likely pathogenic).
- Cryohydrocytosis also has ClinVar records linked to SLC4A1 variants; they fall mostly in different places as the Hereditary spherocytosis variants (9 pathogenic / likely pathogenic).
- Elliptocytosis also has ClinVar records linked to SPTB variants; they fall mostly in different places as the Hereditary spherocytosis variants (3 pathogenic / likely pathogenic).
- Elliptocytosis also has ClinVar records linked to SPTA1 variants; they fall mostly in different places as the Hereditary spherocytosis variants (3 pathogenic / likely pathogenic).
Diseases related to Hereditary spherocytosis
- Elliptocytosis, also linked to SPTA1 and SPTB
- Renal tubulopathies, also linked to SLC4A1
- Autosomal dominant distal renal tubular acidosis, also linked to SLC4A1
- Cryohydrocytosis, also linked to SLC4A1
- Southeast Asian ovalocytosis, also linked to SLC4A1
- BLOOD GROUP, WALDNER, also linked to SLC4A1
- BLOOD GROUP--SWANN SYSTEM, also linked to SLC4A1
- Distal renal tubular acidosis with anemia, also linked to SLC4A1
Frequently asked questions
Which genes have records linked to Hereditary spherocytosis?
This view contains 3 analyzed proteins: SLC4A1, SPTB, SPTA1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 22 pathogenic or likely pathogenic variants, 145 variants of uncertain significance and 97 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 366 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center